Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D01HTS
|
||||
Former ID |
DIB015586
|
||||
Drug Name |
MIP-1231
|
||||
Synonyms |
MIP-1231; MIP-1232; MIP-1233; MIP-1259; MIP-1260; MIP-1271; MIP-1272; Seprase inhibitors (cancer, imaging); Iodine-131-MIP-1232; Seprase inhibitors (cancer, imaging), Molecular Insight; FAP-alpha antagonists (cancer, imaging), Molecular Insight; Fibroblast-activating protein antagonists (cancer, imaging), Molecular Insight
|
||||
Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Investigative | [543609] | ||
Company |
Molecular Insight Pharmaceuticals Inc
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
C1CCC(N1C(=O)CNC(=O)c1ccc(cc1)[131I])B(O)O
|
||||
Target and Pathway | |||||
Target(s) | Seprase | Target Info | Antagonist | [543609] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.